JP2019501363A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019501363A5 JP2019501363A5 JP2018516113A JP2018516113A JP2019501363A5 JP 2019501363 A5 JP2019501363 A5 JP 2019501363A5 JP 2018516113 A JP2018516113 A JP 2018516113A JP 2018516113 A JP2018516113 A JP 2018516113A JP 2019501363 A5 JP2019501363 A5 JP 2019501363A5
- Authority
- JP
- Japan
- Prior art keywords
- cysteine
- protein
- reactive probe
- moiety
- reactive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 27
- 235000018102 proteins Nutrition 0.000 claims 18
- 108090000623 proteins and genes Proteins 0.000 claims 18
- 102000004169 proteins and genes Human genes 0.000 claims 18
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 14
- 235000018417 cysteine Nutrition 0.000 claims 14
- 239000000523 sample Substances 0.000 claims 13
- 150000003384 small molecules Chemical group 0.000 claims 10
- 210000004027 cell Anatomy 0.000 claims 5
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 claims 4
- -1 N-hydroxysuccinimide (NHS) ester Chemical class 0.000 claims 3
- JVJFIQYAHPMBBX-UHFFFAOYSA-N 4-hydroxynonenal Chemical compound CCCCCC(O)C=CC=O JVJFIQYAHPMBBX-UHFFFAOYSA-N 0.000 claims 2
- 150000001345 alkine derivatives Chemical group 0.000 claims 2
- 238000004458 analytical method Methods 0.000 claims 2
- 230000005764 inhibitory process Effects 0.000 claims 2
- 239000003446 ligand Substances 0.000 claims 2
- 125000003396 thiol group Chemical group [H]S* 0.000 claims 2
- VHRUMKCAEVRUBK-GODQJPCRSA-N 15-deoxy-Delta(12,14)-prostaglandin J2 Chemical compound CCCCC\C=C\C=C1/[C@@H](C\C=C/CCCC(O)=O)C=CC1=O VHRUMKCAEVRUBK-GODQJPCRSA-N 0.000 claims 1
- 102000004506 Blood Proteins Human genes 0.000 claims 1
- 108010017384 Blood Proteins Proteins 0.000 claims 1
- 108010078791 Carrier Proteins Proteins 0.000 claims 1
- 108091006146 Channels Proteins 0.000 claims 1
- 102000034573 Channels Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 claims 1
- 102000006404 Mitochondrial Proteins Human genes 0.000 claims 1
- 108010058682 Mitochondrial Proteins Proteins 0.000 claims 1
- 108010006519 Molecular Chaperones Proteins 0.000 claims 1
- 108091005764 adaptor proteins Proteins 0.000 claims 1
- 102000035181 adaptor proteins Human genes 0.000 claims 1
- HAXFWIACAGNFHA-UHFFFAOYSA-N aldrithiol Chemical compound C=1C=CC=NC=1SSC1=CC=CC=N1 HAXFWIACAGNFHA-UHFFFAOYSA-N 0.000 claims 1
- 150000001336 alkenes Chemical class 0.000 claims 1
- 125000005262 alkoxyamine group Chemical group 0.000 claims 1
- 150000001540 azides Chemical class 0.000 claims 1
- 150000001718 carbodiimides Chemical class 0.000 claims 1
- 210000004292 cytoskeleton Anatomy 0.000 claims 1
- AFOSIXZFDONLBT-UHFFFAOYSA-N divinyl sulfone Chemical compound C=CS(=O)(=O)C=C AFOSIXZFDONLBT-UHFFFAOYSA-N 0.000 claims 1
- 125000005179 haloacetyl group Chemical group 0.000 claims 1
- 238000011065 in-situ storage Methods 0.000 claims 1
- 230000003993 interaction Effects 0.000 claims 1
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 claims 1
- 238000002372 labelling Methods 0.000 claims 1
- 238000004949 mass spectrometry Methods 0.000 claims 1
- RDBMUARQWLPMNW-UHFFFAOYSA-N phosphanylmethanol Chemical compound OCP RDBMUARQWLPMNW-UHFFFAOYSA-N 0.000 claims 1
- 238000000575 proteomic method Methods 0.000 claims 1
- 108091006024 signal transducing proteins Proteins 0.000 claims 1
- 102000034285 signal transducing proteins Human genes 0.000 claims 1
- GWIKYPMLNBTJHR-UHFFFAOYSA-M thiosulfonate group Chemical group S(=S)(=O)[O-] GWIKYPMLNBTJHR-UHFFFAOYSA-M 0.000 claims 1
- 238000013518 transcription Methods 0.000 claims 1
- 230000035897 transcription Effects 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562244881P | 2015-10-22 | 2015-10-22 | |
| US62/244,881 | 2015-10-22 | ||
| US201662345710P | 2016-06-03 | 2016-06-03 | |
| US62/345,710 | 2016-06-03 | ||
| PCT/US2016/058308 WO2017070611A1 (en) | 2015-10-22 | 2016-10-21 | Cysteine reactive probes and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019501363A JP2019501363A (ja) | 2019-01-17 |
| JP2019501363A5 true JP2019501363A5 (enExample) | 2020-01-30 |
| JP6953400B2 JP6953400B2 (ja) | 2021-10-27 |
Family
ID=58558160
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018516113A Active JP6953400B2 (ja) | 2015-10-22 | 2016-10-21 | システイン反応性プローブとその使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US10670605B2 (enExample) |
| EP (1) | EP3365686A4 (enExample) |
| JP (1) | JP6953400B2 (enExample) |
| CA (1) | CA3001847A1 (enExample) |
| WO (1) | WO2017070611A1 (enExample) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10782295B2 (en) | 2013-08-13 | 2020-09-22 | The Scripps Research Institute | Cysteine-reactive ligand discovery in proteomes |
| JP6953400B2 (ja) | 2015-10-22 | 2021-10-27 | ザ スクリプス リサーチ インスティテュート | システイン反応性プローブとその使用 |
| CN109843856B (zh) | 2016-05-18 | 2023-05-02 | 米拉蒂治疗股份有限公司 | Kras g12c抑制剂 |
| US20190216893A1 (en) * | 2016-06-03 | 2019-07-18 | The Scripps Research Institute | Compositions and methods of modulating immune response |
| WO2018136555A2 (en) | 2017-01-18 | 2018-07-26 | The Scripps Research Institute | Photoreactive ligands and uses thereof |
| AU2018215447A1 (en) * | 2017-02-03 | 2019-08-08 | The Regents Of The University Of California | Compositions and methods for inhibiting reticulon 4 |
| WO2018144869A1 (en) * | 2017-02-03 | 2018-08-09 | The Regents Of The University Of California | Compositons and methods for modulating uba5 |
| MX2019009199A (es) * | 2017-02-03 | 2019-10-21 | Univ California | Composiciones y métodos para modular ppp2r1a. |
| EP3688012A4 (en) * | 2017-09-27 | 2021-06-30 | Vividion Therapeutics, Inc. | COMPOUNDS AND METHODS FOR MODULATING PROTEIN DEGRADATION |
| WO2019067741A1 (en) * | 2017-09-27 | 2019-04-04 | The Scripps Research Institute | CONJUGATED PROTEINS AND USES THEREOF |
| WO2019075386A1 (en) | 2017-10-13 | 2019-04-18 | The Regents Of The University Of California | MODULATORS OF MTORC1 |
| KR102861303B1 (ko) | 2017-11-15 | 2025-09-17 | 미라티 테라퓨틱스, 인크. | Ｋｒａｓ ｇ12ｃ 억제제 |
| US10647715B2 (en) | 2017-11-15 | 2020-05-12 | Mirati Therapeutics, Inc. | KRas G12C inhibitors |
| CN111698986B (zh) * | 2017-12-11 | 2023-02-03 | 广州君赫生物科技有限公司 | 双硫仑的新应用 |
| WO2019217307A1 (en) | 2018-05-07 | 2019-11-14 | Mirati Therapeutics, Inc. | Kras g12c inhibitors |
| JP2022500385A (ja) | 2018-09-10 | 2022-01-04 | ミラティ セラピューティクス， インコーポレイテッド | 組み合わせ療法 |
| ES3004338T3 (en) | 2018-09-10 | 2025-03-12 | Mirati Therapeutics Inc | Combination therapies |
| KR102871791B1 (ko) | 2018-09-10 | 2025-10-15 | 미라티 테라퓨틱스, 인크. | 병용 요법 |
| WO2020055761A1 (en) | 2018-09-10 | 2020-03-19 | Mirati Therapeutics, Inc. | Combination therapies |
| CA3112129A1 (en) | 2018-12-05 | 2020-06-11 | Mirati Therapeutics, Inc. | Combination therapies |
| JP7592601B2 (ja) | 2019-01-10 | 2024-12-02 | ミラティ セラピューティクス， インコーポレイテッド | Ｋｒａｓ ｇ１２ｃ阻害剤 |
| WO2020214336A2 (en) | 2019-03-21 | 2020-10-22 | University Of Virginia Patent Foundation | Sulfur-heterocycle exchange chemistry and uses thereof |
| WO2021026162A1 (en) * | 2019-08-05 | 2021-02-11 | Bridgene Biosciences, Inc. | Method for proteome-wide discovery of covalent ligands and compositions thereof |
| CA3148745A1 (en) | 2019-08-29 | 2021-03-04 | Xiaolun Wang | Kras g12d inhibitors |
| CN114761012B (zh) | 2019-09-24 | 2025-03-21 | 米拉蒂治疗股份有限公司 | 组合疗法 |
| JP7728251B2 (ja) * | 2019-10-15 | 2025-08-22 | ジュニャーナ セラピューティクス インコーポレイテッド | 反応性アフィニティプローブ相互作用探索プラットフォーム |
| WO2021076755A1 (en) * | 2019-10-16 | 2021-04-22 | The Scripps Research Institute | An activity-guide map of electrophile-cysteine interactions in primary human immune cells |
| US20240123078A1 (en) * | 2019-10-16 | 2024-04-18 | Vividion Therapeutics, Inc. | Compounds and methods for modulating immune-related proteins |
| CN111063389B (zh) * | 2019-12-04 | 2021-10-29 | 浙江工业大学 | 一种基于深度卷积神经网络的配体绑定残基预测方法 |
| KR20220130126A (ko) | 2019-12-20 | 2022-09-26 | 미라티 테라퓨틱스, 인크. | Sos1 억제제 |
| US12286431B2 (en) | 2020-09-11 | 2025-04-29 | Mirati Therapeutics, Inc. | Crystalline forms of a KRas G12C inhibitor |
| CN112255396A (zh) * | 2020-10-15 | 2021-01-22 | 南开大学 | 一种测量小分子药物抑制蛋白核酸互作的单分子力学方法 |
| US12398154B2 (en) | 2020-12-15 | 2025-08-26 | Mirati Therapeutics, Inc. | Azaquinazoline pan-KRas inhibitors |
| EP4262803A4 (en) | 2020-12-16 | 2025-03-12 | Mirati Therapeutics, Inc. | Tetrahydropyridopyrimidine pan-kras inhibitors |
| WO2022240966A1 (en) * | 2021-05-11 | 2022-11-17 | Opna Immuno-Oncology Sa | Compounds and methods for yap/tead modulation and indications therefor |
| US20250034216A1 (en) * | 2021-11-22 | 2025-01-30 | The Scripps Research Institute | Stereoselective covalent ligands for oncogenic and immunological proteins |
| US20260079154A1 (en) * | 2022-09-12 | 2026-03-19 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Composition, device, system, and methods for detecting environmental toxicants |
| US20260103438A1 (en) * | 2022-09-28 | 2026-04-16 | The General Hospital Corporation | Probes and methods to identify ligandable fatty acylation sites for therapeutic target identification |
| CN116466423B (zh) * | 2023-04-26 | 2026-05-01 | 中国科学院化学研究所 | 一种手性选择的光滤波器及其应用 |
| CN116790698B (zh) * | 2023-06-21 | 2024-06-18 | 南京大学 | 基于氧化脱羧酶的硫醛合成方法及其应用 |
| WO2025182683A1 (ja) * | 2024-02-29 | 2025-09-04 | 国立大学法人 東京大学 | タンパク質の活性／反応性部位の、活性／反応性の評価方法 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6344330B1 (en) | 1998-03-27 | 2002-02-05 | The Regents Of The University Of California | Pharmacophore recombination for the identification of small molecule drug lead compounds |
| AU5477100A (en) * | 1999-06-10 | 2001-01-02 | Pharmacia & Upjohn Company | Caspase-8 crystals, models and methods |
| EP1441228B1 (en) * | 2000-11-21 | 2006-06-28 | Sunesis Pharmaceuticals, Inc. | An extended tethering approach for rapid identification of ligands |
| WO2005118833A2 (en) | 2004-06-01 | 2005-12-15 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with sterile-alpha motif and leucine zipper containing kinase (zak) |
| US7935479B2 (en) | 2004-07-19 | 2011-05-03 | Cell Biosciences, Inc. | Methods and devices for analyte detection |
| US8314215B2 (en) * | 2006-08-04 | 2012-11-20 | The Board Of Trustees Of The Leland Stanford Junior University | Mild chemically cleavable linker system |
| WO2008029924A1 (en) * | 2006-09-08 | 2008-03-13 | Dainippon Sumitomo Pharma Co., Ltd. | Cyclic aminoalkylcarboxamide derivative |
| AU2007324111A1 (en) | 2006-10-02 | 2008-05-29 | The Scripps Research Institute | An enzyme regulating ether lipid signaling pathways |
| CN101219219B (zh) * | 2007-01-10 | 2013-02-13 | 北京普罗吉生物科技发展有限公司 | 包含血管抑素或其片段的复合物、其制备方法及应用 |
| EP1947193A1 (en) | 2007-01-17 | 2008-07-23 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Screening method for anti-diabetic compounds |
| CA2679643A1 (en) * | 2007-03-09 | 2008-09-18 | The University Of British Columbia | Procaspase 8-mediated disease targeting |
| WO2009106211A1 (en) * | 2008-02-26 | 2009-09-03 | Ludwig-Maximilians-Universität München | Beta-lactones as antibacterial agents |
| WO2013192364A1 (en) * | 2012-06-22 | 2013-12-27 | The University Of Vermont And State Agricultural College | Treatments of oxidative stress conditions |
| EP3004141A4 (en) | 2013-06-03 | 2017-05-31 | Acetylon Pharmaceuticals, Inc. | Histone deacetylase ( hdac) biomarkers in multiple myeloma |
| US10782295B2 (en) | 2013-08-13 | 2020-09-22 | The Scripps Research Institute | Cysteine-reactive ligand discovery in proteomes |
| WO2016029037A1 (en) | 2014-08-21 | 2016-02-25 | Srx Cardio, Llc | Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(pcsk9) protein activity |
| JP6953400B2 (ja) | 2015-10-22 | 2021-10-27 | ザ スクリプス リサーチ インスティテュート | システイン反応性プローブとその使用 |
| WO2018136555A2 (en) | 2017-01-18 | 2018-07-26 | The Scripps Research Institute | Photoreactive ligands and uses thereof |
-
2016
- 2016-10-21 JP JP2018516113A patent/JP6953400B2/ja active Active
- 2016-10-21 WO PCT/US2016/058308 patent/WO2017070611A1/en not_active Ceased
- 2016-10-21 US US15/331,745 patent/US10670605B2/en active Active
- 2016-10-21 CA CA3001847A patent/CA3001847A1/en active Pending
- 2016-10-21 EP EP16858391.2A patent/EP3365686A4/en not_active Withdrawn
-
2020
- 2020-06-02 US US16/890,966 patent/US20200292555A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sprung Jr et al. | Equivalence of protein inventories obtained from formalin-fixed paraffin-embedded and frozen tissue in multidimensional liquid chromatography-tandem mass spectrometry shotgun proteomic analysis | |
| Macklin et al. | Recent advances in mass spectrometry based clinical proteomics: applications to cancer research | |
| Chen et al. | Measuring the dynamics of E. coli ribosome biogenesis using pulse-labeling and quantitative mass spectrometry | |
| Eaton | Protein thiol oxidation in health and disease: techniques for measuring disulfides and related modifications in complex protein mixtures | |
| Nikolovska-Coleska | Studying protein-protein interactions using surface plasmon resonance | |
| Wright et al. | Mass spectrometry-based expression profiling of clinical prostate cancer | |
| Chen et al. | Capillary nano-immunoassays: advancing quantitative proteomics analysis, biomarker assessment, and molecular diagnostics | |
| DE69938623D1 (de) | Microarrays und ihre verwendungen | |
| Honoré et al. | Functional genomics studied by proteomics | |
| Billakanti et al. | Simultaneous, quantitative detection of five whey proteins in multiple samples by surface plasmon resonance | |
| Stigter et al. | Coupling surface-plasmon resonance and mass spectrometry to quantify and to identify ligands | |
| ATE554106T1 (de) | Antikörper für onkogene stämme von hpv und verfahren zu deren verwendung | |
| Salimi-Moosavi et al. | Rapid affinity measurement of protein–protein interactions in a microfluidic platform | |
| Campion et al. | Protein quantitation and analysis of purity | |
| JP2016535270A5 (enExample) | ||
| Xu et al. | On‐plate enrichment of glycopeptides by using boronic acid functionalized gold‐coated Si wafer | |
| Anders et al. | SPRi-MALDI MS: characterization and identification of a kinase from cell lysate by specific interaction with different designed ankyrin repeat proteins | |
| EP1589341A2 (en) | Method of selective peptide isolation for the identification and quantitative analysis of proteins in complex mixtures | |
| JP2005513507A5 (enExample) | ||
| Hobbs et al. | Biophysical and proteomic characterization strategies for cysteine modifications in Ras GTPases | |
| JP2018072045A (ja) | 人血検査方法及び人血検査用キット | |
| JPWO2021070934A5 (enExample) | ||
| Lei et al. | The breast cancer proteome and precision oncology | |
| Zhang et al. | A dual-labelling strategy for integrated ICPMS and LIF for the determination of peptides | |
| Melles et al. | Electroimmobilization of proinsulin C-peptide to a quartz crystal microbalance sensor chip for protein affinity purification |